Bilimsel Makale Arama | NeuralCipher AI

Açık erişim

GBA1 variants and mortality in Parkinson's disease: A systematic review and meta-analysis.

Chan N, Raphael A, Kim J, Haryanto A, Heshmat S, Khoo TK.

J Parkinsons Dis · 2026-08-07

DOI: 10.1177/1877718x261470604PMID: 42565774

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cholesterol enhances lysosome-autophagosome fusion for better α-synuclein clearance in GBA L444P-mutated Parkinson disease.

Chen M, Liu F, Yang Y, Chen R, Gan L, Sun Y, Yan Y, Xie S, Zhu C, Sun X, Li Y, Zhu S, Liu W, Zuo J, Yang Y, Wang J.

Cell Rep · 2026-08-06

DOI: 10.1016/j.celrep.2026.117800PMID: 42560815

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

E326K GBA polymorphism is associated with clinical and pathological features of synucleinopathy in the absence of overt Parkinson's disease or Lewy body dementia.

Arnold MR, Westaway SK, Woltjer RL, Gray NE, Quinn JF.

J Parkinsons Dis · 2026-07-22

DOI: 10.1177/1877718x261468542PMID: 42484558

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Association of GBA1 status and sex with depression severity and progression in Parkinson's disease.

Mitrotti P, Avenali M, Artusi CA, De Micco R, Giannini G, Calabrese R, Gallo L, Galandra C, Ledda C, Mascia A, Siciliano M, Pagliuca F, Sambati L, Sant'Elia V, Vornetti G, Calandra-Buonaura G, Lopiano L, Lodi R, Tessitore A, Bozzali M, Valente EM.

NPJ Parkinsons Dis · 2026-07-08

DOI: 10.1038/s41531-026-01460-2PMID: 42420305

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

GBA1 variants and dopaminergic imaging in essential tremor with atypical features: A comparative study with Parkinson's disease.

Suoranta M, Kytövuori L, Haataja E, Myller E, Jaakkola E, Noponen T, Eklund M, Nuuttila S, Joutsa J, Murtomäki K, Mertsalmi T, Levo R, Pitkonen M, Scheperjans F, Vahlberg T, Kaasinen V, Martikainen MH.

Parkinsonism Relat Disord · 2026-07-06

DOI: 10.1016/j.parkreldis.2026.108410PMID: 42413462

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Sex-Specific Association of Rasagiline with Motor Progression in GBA1-Associated Parkinson's Disease.

Saragani H, Henner R, Becker-Cohen M, Revel-Vilk S, Zimran A, Harari I, Eichel R, Yahalom G, Cohen ME.

Life (Basel) · 2026-07-01

DOI: 10.3390/life16071103PMID: 42514173

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

GBA mutation exacerbates α-synuclein pathology with involvement of ROS and p38 MAPK signaling in Parkinson's disease.

Xu H, Tang YT, Dong WL, Liu MH, Wang F, Liu CF, Chen JP.

Int Immunopharmacol · 2026-06-30

DOI: 10.1016/j.intimp.2026.117089PMID: 42378827

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Recombinant GBA1 alleles presenting as exon-level deletions by short-read NGS in Parkinson disease: Implications for diagnostic approaches.

Hong YJ, Jang MA, Yang D, Kim JW, Youn J, Cho JW, Jang JH.

J Hum Genet · 2026-06-19

DOI: 10.1038/s10038-026-01486-7PMID: 42321433

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Targeting lysosomal pH restores mitochondrial quality control in GBA1-mutant Parkinson's disease.

Sheshadri P, Costa-Besada MA, Fisher A, Kiraly S, Singh K, Kourouzidou I, Blacker TS, Zeng J, Shirihai OS, Grinstaff MW, Duchen MR.

Transl Neurodegener · 2026-06-17

DOI: 10.1186/s40035-026-00559-zPMID: 42310725

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Analyzing the 'bradykinesia complex' in GBA1-associated Parkinson's disease: A series of three cases.

De Riggi M, Birreci D, Martini A, Aloisio S, Angelini L, Grandolfo AS, Bologna M.

Clin Park Relat Disord · 2026-06-11

DOI: 10.1016/j.prdoa.2026.100462PMID: 42359245

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment.

Menozzi E, Toffoli M, Deleidi M, Di Monte DA, Blandini F, Krainc D, Sidransky E, Schapira AHV.

Lancet Neurol · 2026-06-01

DOI: 10.1016/s1474-4422(26)00090-6PMID: 42127935

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Region-based morphometry in Parkinson's disease patients with GBA mutation and its predictive role for cognition after STN-DBS.

Reimer J, Schumann F, Gruber D, Schneider GH, Krause T, Kühn AA, Krause P.

Parkinsonism Relat Disord · 2026-05-23

DOI: 10.1016/j.parkreldis.2026.108355PMID: 42214115

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

404 makale bulundu

<i>GBA1</i> variants and mortality in Parkinson's disease: A systematic review and meta-analysis.

Cholesterol enhances lysosome-autophagosome fusion for better α-synuclein clearance in GBA L444P-mutated Parkinson disease.

E326K <i>GBA</i> polymorphism is associated with clinical and pathological features of synucleinopathy in the absence of overt Parkinson's disease or Lewy body dementia.

Association of GBA1 status and sex with depression severity and progression in Parkinson's disease.

GBA1 variants and dopaminergic imaging in essential tremor with atypical features: A comparative study with Parkinson's disease.

Sex-Specific Association of Rasagiline with Motor Progression in <i>GBA1</i>-Associated Parkinson's Disease.

GBA mutation exacerbates α-synuclein pathology with involvement of ROS and p38 MAPK signaling in Parkinson's disease.

Recombinant GBA1 alleles presenting as exon-level deletions by short-read NGS in Parkinson disease: Implications for diagnostic approaches.

Targeting lysosomal pH restores mitochondrial quality control in GBA1-mutant Parkinson's disease.

Analyzing the 'bradykinesia complex' in GBA1-associated Parkinson's disease: A series of three cases.

New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment.

Region-based morphometry in Parkinson's disease patients with GBA mutation and its predictive role for cognition after STN-DBS.

Filtreler